Herbal Extract Wound Dressing for Diabetic Healing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for wound healing in diabetic patients are inadequate and expensive, with limited effective options available for enhancing the healing of skin disorders such as wounds and bedsores.
Innovation Solution
A pharmaceutical composition combining therapeutically effective amounts of Plectranthus amboinicus Benth crude extracts and Centella asiatica Urban whole plant extracts, comprising asiaticoside, is used topically to enhance wound healing, formulated as ointments or wound dressings.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current commercial treatments (e.g., PDGF Regranex Gel) are used for wound healing in diabetic patients, then wound healing effectiveness is improved, but treatment cost increases significantly
Solution Approach 1:
The patent replaces expensive commercial treatments with a cost-effective formulation using traditional herbal extracts (Centella asiatica and Plectranthus amboinicus) that can be prepared at lower cost while maintaining therapeutic efficacy for wound healing in diabetic patients
Solution Approach 2:
The invention combines multiple herbal extracts (Centella asiatica containing asiaticoside and madecassic acid, and Plectranthus amboinicus) into a composite pharmaceutical formulation that synergistically enhances wound healing effectiveness while reducing dependency on expensive single-ingredient commercial products
2Ease of manufacture
If traditional herbal extracts are used for wound healing, then treatment cost is reduced, but wound healing effectiveness may be insufficient
Solution Approach 1:
The patent merges multiple traditional herbal extracts (Centella asiatica and Plectranthus amboinicus) into a single pharmaceutical formulation, combining their individual wound-healing properties to achieve synergistic effectiveness that addresses the insufficiency of single-herb treatments while maintaining cost advantages
3Ease of operation
If diabetic patients receive standard wound care, then basic wound management is provided, but healing rate is significantly slower compared to non-diabetic patients
Solution Approach 1:
The patent applies pharmaceutical formulations containing specific concentrations of herbal extracts (asiaticoside, madecassic acid, and Plectranthus amboinicus components) to change the biochemical parameters of the wound environment, thereby accelerating the healing rate in diabetic patients beyond what standard care achieves
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention provides a pharmaceutical composition for treating skin disorders, including enhancing the healing of wounds for diabetic patients. Specifically, this invention relates to the use of the extracts of Plectranthus amboinicus and Centella asiatica for improving skin disorders, including enhancing the healing of wounds for diabetic patients, and a pharmaceutical composition comprising the extracts of Plectranthus amboinicus and Centella asiatica as well as a wound dressing comprising the same. The invention also provides a method for preparing the crude extract and extract of Plectranthus amboinicus.